Pay in 4 interest-free payments of $6.91 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
Expected 12-month results include 15 to 20% body weight loss (65 to 100+ pounds for a 400-pound person), 6 to 10 inch waist circumference reduction, transformative improvement in daily functional capacity, and resolution or significant improvement of multiple obesity-related conditions
K.h, Tarnovskaya, S
Semaglutide, the active ingredient in Ozempic and Wegovy, may help prevent kidney damage in people with obesity
it does not carry the multi-year post-marketing safety record of an approved drug
Compounded medications are not FDA-approved, and the FDA does not review each compounded preparation for safety, effectiveness, or quality before it reaches a patient
US$ 28.65
US$ 27.39
US$ 26.90
US$ 23.81
